Insulet (PODD) Change in Receivables (2010 - 2026)
Insulet's (PODD) quarterly Change in Receivables came in at $209.8 million in Q4 2025, up 832.44% YoY from $22.5 million in Q4 2024, and up 13012.5% on a QoQ basis from $1.6 million in Q3 2025.
Insulet (PODD) Change in Receivables (2010 - 2026) Analysis & Trends
Insulet (PODD) has 14 years of Change in Receivables data on file, last reported at $209.8 million in Q4 2025.
- Quarterly Change in Receivables rose 832.44% year-over-year to $209.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $247.0 million (up 339.5% YoY) and the FY2025 annual result came in at $253.2 million, up 1398.22% from the prior year.
- Change in Receivables advanced to $209.8 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $209.8 million in Q4 2025 to a low of -$33.1 million in Q1 2024.
- A 5-year average of $21.4 million and a median of $7.0 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables sank 430.56% — and 2025, when it surged 832.44%.
- Tracing PODD's Change in Receivables over 5 years: stood at $19.6 million in 2021, then plunged by 178.57% to -$15.4 million in 2022, then soared by 646.75% to $84.2 million in 2023, then slumped by 73.28% to $22.5 million in 2024, then surged by 832.44% to $209.8 million in 2025.
- The last three Change in Receivables figures came in at $209.8 million (Q4 2025), $1.6 million (Q3 2025), and $35.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Insulet | 10.34 Bn | 9.80 Bn | 562.60 Mn | 46.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.30 Mn |
| Jun 30, 2026 | 46.30 Mn |
| Mar 31, 2026 | 30.60 Mn |
| Mar 31, 2026 | 30.60 Mn |
| Dec 31, 2025 | 209.80 Mn |
| Dec 31, 2025 | 209.80 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | -16.80 Mn |
| Sep 30, 2024 | -16.80 Mn |
| Jun 30, 2024 | 44.30 Mn |
| Jun 30, 2024 | 44.30 Mn |
| Mar 31, 2024 | -33.10 Mn |
| Mar 31, 2024 | -33.10 Mn |